|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.335 USD | +2.02% |
|
-3.07% | -31.01% |
| 04:50pm | Ocular Therapeutix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 03:23pm | Ocular Therapeutix's Q2 Net Loss Widens, Revenue Flat | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- OCUL Stock
- Consensus Ocular Therapeutix, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
